DAWN

DAWN Other Income/Expenses (Net)

$18.45MTTM · USD

Period ending:

DAWN FY Other Income/Expenses (Net)USD
DAWN FY Other Income/Expenses (Net)2019-12-31: -$2.08M2020-12-31: -$30.03M2021-12-31: -$11.00K2022-12-31: $4.73M2023-12-31: $17.15M2024-12-31: $128.92M2025-12-31: $18.45M$128.92M-$30.03M
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

DAWN other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Day One Biopharmaceuticals Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
18,452,000
128,918,000
17,147,000
4,728,000
-11,000
-30,031,000
-2,079,000

Compare other income/expenses (net)

All DAWN financial metrics · DAWN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.